NKO Advises Dr Max on Acquisition of Melem Pharmacy

NKO Advises Dr Max on Acquisition of Melem Pharmacy

Serbia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

NKO has advised Dr Max on its acquisition of Melem Pharmacy in Serbia from Vladimir Cupic. Bajic & Popovic reportedly advised the seller.

According to NKO, Melem is based in Zabalj, and it comprises 6 retail units located in Zabalj, Zrenjanin, and Novi Sad. This is the seventh pharmacy chain acquisition for Dr Max in 2023.

NKO has recently advised Dr Max on its acquisitions of the Dr Ristic Pharmacy Chain (as reported by CEE Legal Matters on November 9, 2023), the Uniprom pharmacy chain in Zajecar (as reported by CEE Legal Matters on October 4, 2023), Nova Pharm (as reported by CEE Legal Matters on March 28, 2023), Beolek (as reported on March 9, 2023), Cvejic (as reported on January 31, 2023), as well as AU Medis Lek (as reported by CEE Legal Matters on January 6, 2023), 

The firm had also advised the Dr Max Group on its acquisition of a number of other pharmacy chains in Serbia, in 2022, including Pancevo-based AU Kod Suncanog Sata and Veliko Gradiste-based AU Selic (as reported by CEE Legal Matters on October 11, 2022), Belgrade-based K-Pharma (as reported on June 8, 2022), the Janja pharmacy chain (as reported on March 28, 2022), and the Zlatni Lav pharmacies (as reported on January 5, 2022).

The NKO team included Partners Djordje Nikolic and Branko Jankovic, and Associate Goran Mihajlovic.